IL-2 induces in vivo suppression by CD4+
β
Susan Brandenburg; Takeshi Takahashi; Maurus deβlaβRosa; Marko Janke; Gabriele K
π
Article
π
2008
π
John Wiley and Sons
π
English
β 403 KB
## Abstract Interleukinβ2 (ILβ2) treatment is currently used to enhance T cellβmediated immune responses against tumors or in viral infections. At the same time, ILβ2 is essential for the peripheral homeostasis of CD4^+^CD25^+^Foxp3^+^ regulatory T cells (Treg). In our study, we show that ILβ2 is a